Shi Z - Search Results

1

Correlation of radiotherapy with prognosis of elderly patients with hormone receptor-positive breast cancer according to immunohistochemical subtyping.

Zhi X, Yang X, Pan T, Liu J, Chen X, Lou L, Shi Z, Zhang J. Zhi X, et al. Among authors: shi z. Chin J Cancer Res. 2019 Jun;31(3):471-480. doi: 10.21147/j.issn.1000-9604.2019.03.09. Chin J Cancer Res. 2019. PMID: 31354216 Free PMC article.

2

Efficacy and feasibility of the immunomagnetic separation based diagnosis for detecting sentinel lymph node metastasis from breast cancer.

Zhi XC, Zhang M, Meng TT, Zhang XB, Shi ZD, Liu Y, Liu JJ, Zhang S, Zhang J. Zhi XC, et al. Int J Nanomedicine. 2015 Apr 7;10:2775-84. doi: 10.2147/IJN.S72263. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25897222 Free PMC article.

3

microRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7.

Liu J, Zhou Y, Shi Z, Hu Y, Meng T, Zhang X, Zhang S, Zhang J. Liu J, et al. Among authors: shi z. DNA Cell Biol. 2016 Sep;35(9):521-9. doi: 10.1089/dna.2016.3282. Epub 2016 Jun 15. DNA Cell Biol. 2016. PMID: 27303812

4

MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions.

Shi Z, Li Y, Qian X, Hu Y, Liu J, Zhang S, Zhang J. Shi Z, et al. J Cancer. 2017 Sep 2;8(15):3037-3048. doi: 10.7150/jca.19315. eCollection 2017. J Cancer. 2017. PMID: 28928895 Free PMC article.

5

Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin-proteasomal degradation of COX-2.

Pan T, Zhou D, Shi Z, Qiu Y, Zhou G, Liu J, Yang Q, Cao L, Zhang J. Pan T, et al. Among authors: shi z. Cancer Lett. 2020 Jul 10;482:102-111. doi: 10.1016/j.canlet.2019.11.003. Epub 2019 Nov 6. Cancer Lett. 2020. PMID: 31705927

6

Long non-coding RNA SNHG22 facilitates the malignant phenotypes in triple-negative breast cancer via sponging miR-324-3p and upregulating SUDS3.

Fang X, Zhang J, Li C, Liu J, Shi Z, Zhou P. Fang X, et al. Among authors: shi z. Cancer Cell Int. 2020 Jun 17;20:252. doi: 10.1186/s12935-020-01321-9. eCollection 2020. Cancer Cell Int. 2020. PMID: 32565736 Free PMC article.

7

Chidamide Combined With Doxorubicin Induced p53-Driven Cell Cycle Arrest and Cell Apoptosis Reverse Multidrug Resistance of Breast Cancer.

Cao L, Zhao S, Yang Q, Shi Z, Liu J, Pan T, Zhou D, Zhang J. Cao L, et al. Among authors: shi z. Front Oncol. 2021 Mar 2;11:614458. doi: 10.3389/fonc.2021.614458. eCollection 2021. Front Oncol. 2021. PMID: 33738256 Free PMC article.

8

Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.

Yang Q, Zhao S, Shi Z, Cao L, Liu J, Pan T, Zhou D, Zhang J. Yang Q, et al. Among authors: shi z. J Exp Clin Cancer Res. 2021 Apr 6;40(1):120. doi: 10.1186/s13046-021-01901-1. J Exp Clin Cancer Res. 2021. PMID: 33823894 Free PMC article.

9

Over-Expression of Centromere Protein U Participates in the Malignant Neoplastic Progression of Breast Cancer.

Hao X, Qiu Y, Cao L, Yang X, Zhou D, Liu J, Shi Z, Zhao S, Zhang J. Hao X, et al. Among authors: shi z. Front Oncol. 2021 Mar 23;11:615427. doi: 10.3389/fonc.2021.615427. eCollection 2021. Front Oncol. 2021. PMID: 33833984 Free PMC article.

10

Deciphering the performance of polo-like kinase 1 in triple-negative breast cancer progression according to the centromere protein U-phosphorylation pathway.

Zhao S, Geng Y, Cao L, Yang Q, Pan T, Zhou D, Liu J, Shi Z, Zhang J. Zhao S, et al. Among authors: shi z. Am J Cancer Res. 2021 May 15;11(5):2142-2158. eCollection 2021. Am J Cancer Res. 2021. PMID: 34094674 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,404 results

Search Page

Filters